You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

focal adhesion kinase inhibitor

Showing 1 - 25 of 9,984
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Cancer, Cancer of the Pancreas, Pancreas Adenocarcinoma Trial in Saint Louis (device, drug, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • MR-guided stereotactic body radiation therapy
  • +3 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 29, 2023

Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,

Recruiting
  • Intracranial Meningioma
  • +2 more
  • Birmingham, Alabama
  • +707 more
Sep 25, 2022

Pancreatic Cancer, Adenocarcinoma Trial in Canada (GSK2256098, Trametinib)

Active, not recruiting
  • Pancreatic Cancer
  • Adenocarcinoma
  • Hamilton, Ontario, Canada
  • +3 more
May 12, 2022

Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 17, 2022

Malignant Pleural Mesothelioma Trial in Boston (VS-6063)

Terminated
  • Malignant Pleural Mesothelioma
  • Boston, Massachusetts
    Brigham and Women's Hospital
May 13, 2021

Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma Trial in Australia (AMP945 ascending doses, AMP945 RP2D)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • AMP945 ascending doses
  • AMP945 RP2D
  • St Leonards, New South Wales, Australia
  • +6 more
Dec 7, 2022

Nsclc Trial in Spain (Repotrectinib, Osimertinib)

Recruiting
  • Nsclc
  • Málaga, Andalucia, Spain
  • +3 more
Jun 29, 2022

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Neurofibromatosis 1, Neurofibroma Plexiform Trial in Shanghai (Selumetinib)

Active, not recruiting
  • Neurofibromatosis 1
  • Neurofibroma Plexiform
  • Shanghai, China
  • +1 more
Jan 13, 2023

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in Tianjin (NTQ2494 tablet)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • NTQ2494 tablet
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 17, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2 Trial in Worldwide (Gilteritinib, Midostaurin)

Suspended
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome With Excess Blasts-2
  • Adelaide, Australia
  • +193 more
Jan 5, 2023

Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))

Not yet recruiting
  • Lung Cancer
  • Non Small Cell Lung Cancer
  • Amivantamab 1050mg
  • +2 more
  • Aurora, Colorado
  • +2 more
Apr 25, 2023

Waldenstrom Macroglobulinemia, B-Cell Lymphoproliferative Disorder Trial in Boston (Pirtobrutinib, Venetoclax, Allopurinol)

Not yet recruiting
  • Waldenstrom Macroglobulinemia
  • B-Cell Lymphoproliferative Disorder
  • Boston, Massachusetts
  • +2 more
Feb 18, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Liposarcoma, Metastatic Liposarcoma Trial in Boston, Saint Louis, New York (MGCD516)

Active, not recruiting
  • Liposarcoma
  • Metastatic Liposarcoma
  • Boston, Massachusetts
  • +2 more
Nov 23, 2022

Advanced Solid Tumors, Solid Tumors, Pancreatic Cancer Trial in Rochester, Saint Louis (Defactinib, Pembrolizumab, Gemcitabine)

Completed
  • Advanced Solid Tumors
  • +2 more
  • Defactinib
  • +2 more
  • Rochester, Minnesota
  • +1 more
Jul 18, 2021

Advanced Lung Non-Squamous Non-Small Cell Carcinoma, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Stage III Lung

Recruiting
  • Advanced Lung Non-Squamous Non-Small Cell Carcinoma
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

Recruiting
  • Pheochromocytoma, Metastatic
  • +3 more
  • Contrast-enhanced ultrasound(CEUS)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 28, 2023

Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Nivolumab
  • +2 more
  • Springdale, Arkansas
  • +33 more
Nov 22, 2022

NSCLC Trial in Davis, San Francisco (Ceritinib, Trametinib)

Terminated
  • Non-small Cell Lung Cancer
  • Davis, California
  • +1 more
Dec 22, 2022

Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • East Melbourne, Victoria, Australia
  • +7 more
Jan 20, 2023

Pancreatic Ductal Adenocarcinoma Trial (combination therapy with no MEKi, combination therapy with MEKi-HCQ, combination therapy

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • combination therapy with no MEKi
  • +3 more
  • (no location specified)
Nov 29, 2022

Treatment, Treatment Side Effects Trial in China (YK-029A)

Recruiting
  • Treatment
  • Treatment Side Effects
  • Hefei, Anhui, China
  • +34 more
Mar 15, 2023

COVID-19 Trial in Chengdu (VV116+SOC, SOC)

Recruiting
  • COVID-19
  • Chengdu, Sichuan, China
    Chengdu Zenitar Biomedical Technology Co., Ltd
Feb 3, 2023